Mr. Fitzgerald is Vice President of Commercial Operations at CNS Vital Signs. Prior to CNS Vital Signs Mr. Fitzgerald had a 28-year career with GlaxoSmithKline Pharmaceuticals holding several key executive positions in commercial, public policy, and R&D. Craig has a rich and diverse educational, business and science background and has presented at Medical Schools and Genetics Symposia globally. He is the co-author several articles on the managerial implications of genetic and internet developments for health care professionals and organizations. His most recent publications are “Customized Medicine for the Masses,” in Pharmaceutical Executive , and “Converging Genetics and Information Technologies and the Emerging Health Care System”, Int’l J. of Healthcare Technology and Management .